Cargando…
Efficacy and Safety of Botulinum Toxin Type A on Persistent Myofascial Pain: A Randomized Clinical Trial
This study assessed the safety and efficacy of three different doses of BoNT-A for persistent myofascial pain (MFP). One hundred female subjects were randomly assigned into five groups (n = 20): oral appliance (OA), saline solution (SS) and three BoNT-A groups with different doses. Pain intensity an...
Autores principales: | De la Torre Canales, Giancarlo, Alvarez-Pinzon, Natalia, Muñoz-Lora, Victor Ricardo Manuel, Vieira Peroni, Leonardo, Farias Gomes, Amanda, Sánchez-Ayala, Alfonso, Haiter-Neto, Francisco, Manfredini, Daniele, Rizzatti-Barbosa, Célia Marisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354430/ https://www.ncbi.nlm.nih.gov/pubmed/32549196 http://dx.doi.org/10.3390/toxins12060395 |
Ejemplares similares
-
Botulinum toxin type A and acupuncture for masticatory myofascial pain: a randomized clinical trial
por: DE LA TORRE CANALES, Giancarlo, et al.
Publicado: (2021) -
Efficacy of Botulinum Toxin Type-A I in the Improvement of Mandibular Motion and Muscle Sensibility in Myofascial Pain TMD Subjects: A Randomized Controlled Trial
por: De la Torre Canales, Giancarlo, et al.
Publicado: (2022) -
Long-Term Effects of a Single Application of Botulinum Toxin Type A in Temporomandibular Myofascial Pain Patients: A Controlled Clinical Trial
por: De la Torre Canales, Giancarlo, et al.
Publicado: (2022) -
Comprehensive evaluation of botulinum toxin treatment outcomes of a patient with persistent myofascial orofacial pain
por: Sitnikova, Victoria, et al.
Publicado: (2021) -
Distribution of depression, somatization and pain-related impairment in patients with chronic temporomandibular disorders
por: Canales, Giancarlo De La Torre, et al.
Publicado: (2019)